Logo image of EPSM

EPSIUM ENTERPRISE LTD (EPSM) Stock Fundamental Analysis

NASDAQ:EPSM - Nasdaq - VGG3090S1065 - Common Stock - Currency: USD

15.17  -2.13 (-12.31%)

Premarket: 14.8 -0.37 (-2.44%)

Fundamental Rating

4

Taking everything into account, EPSM scores 4 out of 10 in our fundamental rating. EPSM was compared to 19 industry peers in the Distributors industry. While EPSM has a great health rating, its profitability is only average at the moment. EPSM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year EPSM was profitable.
In the past year EPSM has reported a negative cash flow from operations.
EPSM Yearly Net Income VS EBIT VS OCF VS FCFEPSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M 2M 3M 4M

1.2 Ratios

EPSM's Return On Assets of 6.93% is fine compared to the rest of the industry. EPSM outperforms 68.42% of its industry peers.
EPSM's Return On Equity of 9.08% is in line compared to the rest of the industry. EPSM outperforms 52.63% of its industry peers.
EPSM's Return On Invested Capital of 8.94% is fine compared to the rest of the industry. EPSM outperforms 63.16% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EPSM is above the industry average of 18.59%.
The last Return On Invested Capital (8.94%) for EPSM is well below the 3 year average (22.67%), which needs to be investigated, but indicates that EPSM had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.93%
ROE 9.08%
ROIC 8.94%
ROA(3y)17.62%
ROA(5y)N/A
ROE(3y)25.93%
ROE(5y)N/A
ROIC(3y)22.67%
ROIC(5y)N/A
EPSM Yearly ROA, ROE, ROICEPSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30 40

1.3 Margins

EPSM's Profit Margin of 3.75% is fine compared to the rest of the industry. EPSM outperforms 68.42% of its industry peers.
EPSM's Profit Margin has declined in the last couple of years.
EPSM's Operating Margin of 4.84% is in line compared to the rest of the industry. EPSM outperforms 57.89% of its industry peers.
In the last couple of years the Operating Margin of EPSM has declined.
The Gross Margin of EPSM (12.92%) is worse than 63.16% of its industry peers.
In the last couple of years the Gross Margin of EPSM has grown nicely.
Industry RankSector Rank
OM 4.84%
PM (TTM) 3.75%
GM 12.92%
OM growth 3Y-23.27%
OM growth 5YN/A
PM growth 3Y-27.33%
PM growth 5YN/A
GM growth 3Y4.84%
GM growth 5YN/A
EPSM Yearly Profit, Operating, Gross MarginsEPSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

9

2. Health

2.1 Basic Checks

EPSM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EPSM has about the same amount of shares outstanding.
There is no outstanding debt for EPSM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSM Yearly Shares OutstandingEPSM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
EPSM Yearly Total Debt VS Total AssetsEPSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

EPSM has an Altman-Z score of 52.72. This indicates that EPSM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 52.72, EPSM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EPSM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 52.72
ROIC/WACC0.92
WACC9.7%
EPSM Yearly LT Debt VS Equity VS FCFEPSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 4.44 indicates that EPSM has no problem at all paying its short term obligations.
The Current ratio of EPSM (4.44) is better than 89.47% of its industry peers.
A Quick Ratio of 2.46 indicates that EPSM has no problem at all paying its short term obligations.
EPSM has a better Quick ratio (2.46) than 84.21% of its industry peers.
Industry RankSector Rank
Current Ratio 4.44
Quick Ratio 2.46
EPSM Yearly Current Assets VS Current LiabilitesEPSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

EPSM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.73%.
Measured over the past years, EPSM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.90% on average per year.
Looking at the last year, EPSM shows a very negative growth in Revenue. The Revenue has decreased by -58.76% in the last year.
EPSM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.73% yearly.
EPS 1Y (TTM)-89.73%
EPS 3Y-35.9%
EPS 5YN/A
EPS Q2Q%-92.54%
Revenue 1Y (TTM)-58.76%
Revenue growth 3Y-11.73%
Revenue growth 5YN/A
Sales Q2Q%-57.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSM Yearly Revenue VS EstimatesEPSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M 25M

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 252.83 indicates a quite expensive valuation of EPSM.
The rest of the industry has a similar Price/Earnings ratio as EPSM.
EPSM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.69.
Industry RankSector Rank
PE 252.83
Fwd PE N/A
EPSM Price Earnings VS Forward Price EarningsEPSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

EPSM's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 210.9
EPSM Per share dataEPSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EPSM!.
Industry RankSector Rank
Dividend Yield N/A

EPSIUM ENTERPRISE LTD

NASDAQ:EPSM (7/23/2025, 8:19:56 PM)

Premarket: 14.8 -0.37 (-2.44%)

15.17

-2.13 (-12.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.4%
Inst Owner ChangeN/A
Ins Owners80.37%
Ins Owner ChangeN/A
Market Cap203.88M
AnalystsN/A
Price TargetN/A
Short Float %6.42%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 252.83
Fwd PE N/A
P/S 10.39
P/FCF N/A
P/OCF N/A
P/B 25.13
P/tB 25.13
EV/EBITDA 210.9
EPS(TTM)0.06
EY0.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.46
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.93%
ROE 9.08%
ROCE 11.47%
ROIC 8.94%
ROICexc 9.15%
ROICexgc 9.15%
OM 4.84%
PM (TTM) 3.75%
GM 12.92%
FCFM N/A
ROA(3y)17.62%
ROA(5y)N/A
ROE(3y)25.93%
ROE(5y)N/A
ROIC(3y)22.67%
ROIC(5y)N/A
ROICexc(3y)26.46%
ROICexc(5y)N/A
ROICexgc(3y)26.46%
ROICexgc(5y)N/A
ROCE(3y)29.15%
ROCE(5y)N/A
ROICexcg growth 3Y-51.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y-51.18%
ROICexc growth 5YN/A
OM growth 3Y-23.27%
OM growth 5YN/A
PM growth 3Y-27.33%
PM growth 5YN/A
GM growth 3Y4.84%
GM growth 5YN/A
F-Score3
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 540.26%
Cap/Sales 0.42%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.44
Quick Ratio 2.46
Altman-Z 52.72
F-Score3
WACC9.7%
ROIC/WACC0.92
Cap/Depr(3y)187.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.23%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.73%
EPS 3Y-35.9%
EPS 5YN/A
EPS Q2Q%-92.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.76%
Revenue growth 3Y-11.73%
Revenue growth 5YN/A
Sales Q2Q%-57.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.65%
EBIT growth 3Y-32.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-179.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-174.8%
OCF growth 3YN/A
OCF growth 5YN/A